Skip to main content

At AGC Pharma Chemicals, we’re always looking ahead, seeking opportunities to collaborate, learn, and innovate. That’s why we are participating in the Organic Process Research and Development Conference (OPR&D), starting today until October 4th, in Barcelona. 

The chemical and pharmaceutical sectors operate in dynamic and constantly evolving environments. The effective transformation of a chemical process into large-scale manufacturing has always held significance. Nevertheless, within today’s economic and regulatory landscape, achieving this efficiently and in an environmentally sustainable manner has become both increasingly critical and complex. OPR&D places its emphasis on addressing these crucial facets of the chemical industry. 

 

Bridging Excellence with Innovation 

As a leading Contract Development and Manufacturing Organization (CDMO) specializing in small molecule APIs and intermediates, our presence at this event aligns perfectly with our mission.  

These events provide a unique platform for us to connect with fellow visionaries in the pharmaceutical and chemical industries. Ad OPR&D, we’ll be showcasing our capabilities with our dedicated R&D team and Business Development team, as we continue our journey toward realizing our vision of enhancing lives through top-quality pharmaceutical products. 

Latest News

AGC PharmaEvents & ConventionsAGC Pharma Chemicals at CPHI Milan 2024: Let’s talk small molecule innovation
30th September 2024

AGC Pharma Chemicals at CPHI Milan 2024: Let’s talk small molecule innovation

AGC Pharma Chemicals is thrilled to announce its participation at CPHI Milan 2024, taking place from October 8-10. CPHI Milan unites industry leaders, pharma professionals and business of all sizes under…
AGC PharmaEvents & ConventionsAGC Pharma Chemicals at NLSDays 2024
10th September 2024

AGC Pharma Chemicals at NLSDays 2024

We are delighted to announce AGC Pharma Chemicals’ participation in NLSDays 2024, scheduled for September 18th to 19th in Malmö, Sweden. The largest Nordic partnering conference dedicated to the life…
AGC PharmaResources & DevelopmentCarbon Footprint and CDMOs: How is AGC Pharma Chemicals addressing it?
24th July 2024

Carbon Footprint and CDMOs: How is AGC Pharma Chemicals addressing it?

The production of medicines, while vital for human health, leaves a substantial environmental footprint. According to the Sustainable Markets Initiative (SMI), the Biopharmacy industry is responsible for 4–5% of all…